DLG4 and craniodiaphyseal dysplasia: Interestingly, treatment with FRAX486 specifically normalizes PSD95, without affecting synaptophysin 1, which is not altered in CDD mouse brain, suggesting that this molecule provides a selective effect at the defective post‐synaptic level.